Post-hematopoietic stem cell transplantation (HSCT) graft-versus-host disease (GVHD) is associated with considerable healthcare costs, and impaired productivity may represent an additional financial burden.
This analysis quantified GVHD-associated indirect costs of productivity loss by comparing work-related disability leave claims between patients with versus without GVHD.
